2002 Fiscal Year Final Research Report Summary
The Role of stress proteins in the aggregation and cytotoxicity of polyglutamine
Project/Area Number |
13210155
|
Research Category |
Grant-in-Aid for Scientific Research on Priority Areas
|
Allocation Type | Single-year Grants |
Review Section |
Biological Sciences
|
Research Institution | Tokyo Metropolitan Organization for Medical Research |
Principal Investigator |
KIMURA Yoko Tokyo Metropolitan Institute of Medical Science, Researcher, 東京都臨床医学総合研究所, 研究員 (80291152)
|
Co-Investigator(Kenkyū-buntansha) |
KAKIZUKA Akira Kyoto University, Graduate school of Biostudies, Professor, 大学院生命科学研究科, 教授 (80204329)
|
Project Period (FY) |
2001 – 2002
|
Keywords | polyglutamine / neurodegerative disease / molecular chaperone / amyloid / AAA superfamily protein / aggregates / Hsp104 / VCP / p97 |
Research Abstract |
The polyglutamine diseases are caused by the expression of expanded unstable CAG repeats that code for polyglutamine in the responsible genes. These diseases are recognized as a type with a conformationally abnormal or amyloid-related proteins. We identified VCP/p97, one of AAA^+ superfamily proteins, that directly binds to polyglutamine in vitro, and that functions as an enhancer of neurodegeration by polyglutamine expressed in a fly model. We also found that vacuolar formation is one of hallmarks followed by cell death by the expression of polyglutamine in cultured cell systems. Hsp104, another member of AAA^+ superfamily proteins, is required for aggregate formation of polyglutamine expressed in yeast. As polyglutamine takes a form of amyoid in various systems, these results suggest a possibility that some molecular chaperones facilitate amyloid formation of polyglutamines. We further investigated how these molecular chaperones work on polyglutamine. We found that a certain amount of pre-existing polyglutamine aggregates are required for Hsp 104 to enhance the polyglutamine aggregation.
|
Research Products
(14 results)